Questions discussed in this category
There was a recall on viscous lidocaine and many of our patients cannot find it. What would you recommend as alternatives?
For instance, do you factor availability of RNAseq, inclusion of normal blood controls, and QNS rates into your decision?
Or offer resection followed by adjuvant therapy?
Please specify how your institution is allocating resources now or will be soon.
How reliable is somatic testing to detect an underlying germline predisposition?
The patient already received PLADO+sorafenib, Y90, and Atezolizumab/Bevacizumab complicated by recurrent episodes of bleeding from esophageal varices....
Would you offer liver transplant in the setting of metastatic disease?
Would you have reservations in treating patients with breast, GI, or pelvic malignancies with radiation alone or concurrent chemoradiation?
What are there most evidence-based options?
Are you placing more weight on patient risk factors such as age >65 or co-morbidities?
How do you prevent early menopause in women? Please comment on freezing of eggs, oophopexy, supine vs prone position, vaginal dialator.
16568183861737316380100171386511946104057381739567693312
Papers discussed in this category
AJNR. American journal of neuroradiology, 1996-02
Proceedings of the National Academy of Sciences of the United States of America, 2015-11-03
Oncologist, 2020 Mar 10
Semin Diagn Pathol, 2016 Dec 23
Journal of the National Cancer Institute, 2016-06
Pediatrics, 2014 Feb 02
N. Engl. J. Med.,
The Journal of urology, 2018-12
N. Engl. J. Med.,
Lancet Oncol., 2014 Feb 18
NEJM Evidence, 2022 Jun 1
Br J Cancer, 2014 Apr 15
Cancer, 2011-06-15
Eur J Cancer, 2017 Nov 28
N. Engl. J. Med., 2019 Sep 28
Lancet Oncol, 2021 Jan 18
J Clin Oncol, 2021 Apr 19
J Clin Oncol, 2003 Jul 01
JAMA, 2019 Apr 16
Head Neck, 2016 Mar 29
The Lancet. Oncology, 2017-05